Latest filing published 20 Aug 2025 for Arcturus Therapeutics Holdings Inc., €18k.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Andy Sassine (board member) discloses dealings in 5 companies, chiefly Icad Inc, Acorn Energy, Inc. and Arcturus Therapeutics Holdings Inc. In total, 75 filings cover trades dated from 12 August 2013 to 15 August 2025.
In open-market terms, that means 33 purchases worth €1.0M on one side and 19 sales worth €2.9M on the other. Taken together, the sales exceed the purchases by €1.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 15 share grants and 1 option exercise. Since January 2025: 2 purchases and no sales on the market.
The median purchase comes to €9,551. Clusters matter here: 3 out of 6 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 20 August 2025, reports an open-market purchase of €18k in Arcturus Therapeutics Holdings Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations